Compare GRANULES INDIA with Jubilant Pharmova - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs JUBILANT PHARMOVA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA JUBILANT PHARMOVA GRANULES INDIA/
JUBILANT PHARMOVA
 
P/E (TTM) x 16.3 13.7 119.0% View Chart
P/BV x 3.6 2.0 179.4% View Chart
Dividend Yield % 0.5 0.8 57.4%  

Financials

 GRANULES INDIA   JUBILANT PHARMOVA
EQUITY SHARE DATA
    GRANULES INDIA
Mar-21
JUBILANT PHARMOVA
Mar-21
GRANULES INDIA/
JUBILANT PHARMOVA
5-Yr Chart
Click to enlarge
High Rs4381,047 41.8%   
Low Rs138251 55.0%   
Sales per share (Unadj.) Rs130.7559.1 23.4%  
Earnings per share (Unadj.) Rs22.251.8 42.9%  
Cash flow per share (Unadj.) Rs28.380.1 35.3%  
Dividends per share (Unadj.) Rs1.505.00 30.0%  
Avg Dividend yield %0.50.8 67.6%  
Book value per share (Unadj.) Rs86.8297.6 29.2%  
Shares outstanding (eoy) m247.67159.28 155.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.21.2 189.8%   
Avg P/E ratio x13.012.5 103.5%  
P/CF ratio (eoy) x10.28.1 125.6%  
Price / Book Value ratio x3.32.2 152.1%  
Dividend payout %6.89.7 70.0%   
Avg Mkt Cap Rs m71,337103,365 69.0%   
No. of employees `000NANA-   
Total wages/salary Rs m3,24321,728 14.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m32,37589,055 36.4%  
Other income Rs m269298 90.1%   
Total revenues Rs m32,64489,354 36.5%   
Gross profit Rs m8,55218,699 45.7%  
Depreciation Rs m1,5154,516 33.5%   
Interest Rs m2632,473 10.6%   
Profit before tax Rs m7,04412,008 58.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5493,764 41.2%   
Profit after tax Rs m5,4958,244 66.7%  
Gross profit margin %26.421.0 125.8%  
Effective tax rate %22.031.3 70.2%   
Net profit margin %17.09.3 183.3%  
BALANCE SHEET DATA
Current assets Rs m19,97029,525 67.6%   
Current liabilities Rs m11,73110,488 111.8%   
Net working cap to sales %25.421.4 119.0%  
Current ratio x1.72.8 60.5%  
Inventory Days Days1613 130.3%  
Debtors Days Days86334 2,567.9%  
Net fixed assets Rs m17,15758,109 29.5%   
Share capital Rs m248159 155.6%   
"Free" reserves Rs m21,26247,248 45.0%   
Net worth Rs m21,51047,407 45.4%   
Long term debt Rs m3,41125,640 13.3%   
Total assets Rs m37,12787,634 42.4%  
Interest coverage x27.85.9 474.7%   
Debt to equity ratio x0.20.5 29.3%  
Sales to assets ratio x0.91.0 85.8%   
Return on assets %15.512.2 126.8%  
Return on equity %25.517.4 146.9%  
Return on capital %29.319.8 147.9%  
Exports to sales %81.90-   
Imports to sales %26.810.2 262.2%   
Exports (fob) Rs m26,528NA-   
Imports (cif) Rs m8,6919,117 95.3%   
Fx inflow Rs m26,52811,207 236.7%   
Fx outflow Rs m8,6919,117 95.3%   
Net fx Rs m17,8372,090 853.4%   
CASH FLOW
From Operations Rs m4,32517,843 24.2%  
From Investments Rs m-2,771-7,390 37.5%  
From Financial Activity Rs m-2,993-17,094 17.5%  
Net Cashflow Rs m-1,441-7,289 19.8%  

Share Holding

Indian Promoters % 41.7 46.5 89.6%  
Foreign collaborators % 0.4 4.2 8.4%  
Indian inst/Mut Fund % 24.0 24.2 99.1%  
FIIs % 0.0 23.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 49.3 117.5%  
Shareholders   239,520 113,776 210.5%  
Pledged promoter(s) holding % 7.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   KWALITY PHARMA  KERALA AYURV  DISHMAN CARBOGEN AMCIS  ORTIN LABS   KABRA DRUGS  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Related Views on News

JUBILANT PHARMOVA 2020-21 Annual Report Analysis (Annual Result Update)

Nov 8, 2021 | Updated on Nov 8, 2021

Here's an analysis of the annual report of JUBILANT PHARMOVA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT PHARMOVA . Also includes updates on the valuation of JUBILANT PHARMOVA .

GRANULES INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of GRANULES INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GRANULES INDIA. Also includes updates on the valuation of GRANULES INDIA.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 24.0% YoY). Sales on the other hand came in at Rs 23 bn (down 2.6% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime(Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GRANULES INDIA SHARE PRICE


Nov 26, 2021 (Close)

TRACK GRANULES INDIA

  • Track your investment in GRANULES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GRANULES INDIA

GRANULES INDIA 8-QTR ANALYSIS

COMPARE GRANULES INDIA WITH

MARKET STATS